8-K: TerrAscend Reports Mixed Q4 and Full Year 2024 Results; Revenue Dips but Cash Flow Remains Positive

TerrAscend reports a slight increase in Q4 revenue but a decrease for the full year, alongside a net loss impacted by impairment charges, while maintaining positive cash flow.

Summary

• TerrAscend Corp. reported its financial results for the fourth quarter and full year ended December 31, 2024.
• Fourth quarter net revenue increased slightly to $74.4 million from $74.2 million in the third quarter of 2024.
• The gross profit margin for Q4 2024 was 50.2%, up from 48.8% in Q3 2024.
• However, the GAAP net loss for Q4 2024 was $30.2 million, compared to a net loss of $21.4 million in Q3 2024, which included a $45.4 million non-cash impairment charge related to the Michigan business.
• Adjusted EBITDA for Q4 2024 was $15.1 million, compared to $13.7 million in Q3 2024.
• For the full year 2024, net revenue was $306.7 million, a decrease from $317.3 million in 2023.
• The GAAP net loss from continuing operations for the full year was $72.7 million, compared to a net loss of $82.3 million in 2023.
• Adjusted EBITDA from continuing operations for the full year was $60.7 million, compared to $68.8 million in 2023.
• The company reported net cash provided by continuing operations of $38.0 million and free cash flow of $28.6 million for the full year 2024.
• TerrAscend achieved its tenth consecutive quarter of positive cash flow from continuing operations and sixth consecutive quarter of positive free cash flow.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While revenue declined year-over-year and there were net losses, the company maintained positive cash flow and improved gross margins in some areas. The management expresses confidence in future growth and efficiency improvements.

Positives

• TerrAscend achieved its tenth consecutive quarter of positive operating cash flow and sixth consecutive quarter of positive free cash flow.
• The company maintained the #1 market share position in New Jersey every quarter in 2024.
• Revenue grew sequentially in Maryland for all four quarters of 2024 while expanding gross margin from 25% to over 50%.
• TerrAscend closed on a senior secured term loan for gross proceeds of $140 million, carrying an interest rate of 12.75%, maturing in August 2028 and containing no warrants or prepayment penalties.
• The company implemented a company-wide ERP system, enhancing efficiency across departments and providing improved data visibility and control.
• TerrAscend completed a series of initiatives that are expected to reduce General & Administrative expenses year-over-year in 2025 by at least $10 million.

Negatives

• The company reported a GAAP net loss of $30.2 million in Q4 2024, including a $45.4 million non-cash impairment charge related to its Michigan business.
• Full year 2024 net revenue was $306.7 million, down from $317.3 million in 2023.
• The decline in retail sales in Michigan was driven by reduced foot traffic related to reductions in discounting and promotions driven by the Company's ongoing efforts to expand gross margin.
• The decline in New Jersey was driven by an increase in retail competition related to store openings across the state.
• Gross profit margin for the full year 2024 was 48.9% as compared to 50.3% for the full year 2023.

Risks

• The company faces risks related to federal, state, provincial, territorial, local and foreign government laws, rules and regulations, including federal and state laws in the United States relating to cannabis operations in the United States.
• Current and future market conditions could impact the company's performance.
• The company's ability to obtain and maintain licenses, approvals, and permits is a risk factor.
• The enforcement of federal laws in the United States is a significant risk to the business of TerrAscend and any proceedings brought against TerrAscend thereunder may adversely affect TerrAscends operations and financial performance.

Future Outlook

The company anticipates continued growth and operational efficiencies, with a focus on core business expansion and strategic greenfield opportunities. They expect to reduce General & Administrative expenses year-over-year in 2025 by at least $10 million.

Management Comments

• Jason Wild, Executive Chairman of TerrAscend, stated that the business performed ahead of expectations in the fourth quarter.
• Jason Wild is particularly excited about Pennsylvania in anticipation of proposed adult-use legislation.
• Jason Wild noted that the company completed a non-dilutive debt financing, aided by their $150 million of owned real estate, extending the vast majority of their debt maturities to late 2028.
• Jason Wild expressed confidence in the company's ability to drive operational efficiencies and growth of its core business while judiciously pursuing multiple greenfield expansion opportunities at increasingly attractive prices.

Industry Context

TerrAscend is operating in a competitive North American cannabis market, with increasing competition in key states like New Jersey and Michigan. The company is focusing on expanding in growth markets like Maryland and preparing for potential adult-use legalization in Pennsylvania. Their performance is influenced by regulatory changes, market dynamics, and their ability to maintain market share and optimize operations.

Comparison to Industry Standards

• TerrAscend's gross margin of approximately 50% is fairly standard compared to other multi-state operators (MSOs) in the cannabis industry.
• Companies like Curaleaf and Green Thumb Industries often report gross margins in a similar range.
• However, TerrAscend's adjusted EBITDA margin of around 20% is competitive but not leading, as some top-tier MSOs can achieve margins closer to 30%.
• The impairment charges related to the Michigan business are not uncommon in the cannabis industry, as companies re-evaluate asset values in response to market changes and regulatory developments.
• TerrAscend's focus on positive cash flow aligns with the broader industry trend of prioritizing profitability and financial sustainability.

Management Changes

Stakeholder Impact

• Shareholders may be concerned about the year-over-year revenue decline and net losses, but reassured by the positive cash flow and strategic initiatives.
• Employees may be affected by the company's cost reduction initiatives, but also benefit from the company's growth in key markets.
• Customers can expect a broader product portfolio and improved service as the company expands its cultivation and manufacturing capabilities.
• Suppliers and creditors should be confident in the company's ability to meet its obligations due to its positive cash flow and debt financing.

Next Steps

• The company expects the acquisition of Ohio Ratio Cannabis to close in the coming weeks, subject to regulatory approval.
• TerrAscend plans to continue the expansion of cultivation and manufacturing in Boonton, New Jersey.
• The company will continue the expansion of its Maryland cultivation facility, with the first harvest expected during the second quarter of 2025.
• TerrAscend will continue preparations for anticipated Pennsylvania adult-use implementation.
• The company will focus on initiatives to reduce General & Administrative expenses year-over-year in 2025 by at least $10 million.

Key Dates

Keywords

TerrAscend, cannabis, financial results, revenue, EBITDA, cash flow, market share, impairment charge, Maryland, New Jersey